I agree that one needs to hedge, but please remember that there is a difference between vaccine development and contract manufacturing of vaccines, and the Swiss have, for example, contract manufacturers that are particularly good. I think a combination of smarter sourcing and diversified sourcing, where I'd fully agree with you, is an alternative to spending a lot of funding on building up production capacity, which might not be well directed.
On April 16th, 2021. See this statement in context.